AAA

ANAGENICS LIMITED

No trades
See on Supercharts
Market capitalization
‪4.61 M‬AUD
−0.009AUD
‪−2.67 M‬AUD
‪9.11 M‬AUD
Beta (1Y)
2.81

About ANAGENICS LIMITED

CEO
Karen Anne Matthews
Headquarters
Sydney
Founded
2004
ISIN
AU0000198095
FIGI
BBG000CSRML3
Anagenics Ltd. is a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. It operates through the Anagenics Corporate and Consumer and Health segments. The company was founded on October 8, 2004 and is headquartered in Sydney, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AN1 is 0.009 AUD — it has decreased by 10.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ANAGENICS LIMITED stocks are traded under the ticker AN1.
ANAGENICS LIMITED is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
AN1 stock is 11.11% volatile and has beta coefficient of 2.81. Check out the list of the most volatile stocks — is ANAGENICS LIMITED there?
Yes, you can track ANAGENICS LIMITED financials in yearly and quarterly reports right on TradingView.
AN1 stock has fallen by 18.18% compared to the previous week, the month change is a 30.77% fall, over the last year ANAGENICS LIMITED has showed a 65.38% decrease.
AN1 net income for the last quarter is ‪−1.95 M‬ AUD, while the quarter before that showed ‪−1.21 M‬ AUD of net income which accounts for −61.44% change. Track more ANAGENICS LIMITED financial stats to get the full picture.
Today ANAGENICS LIMITED has the market capitalization of ‪4.61 M‬, it has decreased by 14.29% over the last week.
No, AN1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AN1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANAGENICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
AN1 reached its all-time high on Nov 4, 2010 with the price of 1.915 AUD, and its all-time low was 0.010 AUD and was reached on Jun 26, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANAGENICS LIMITED technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANAGENICS LIMITED stock shows the sell signal. See more of ANAGENICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ANAGENICS LIMITED EBITDA is ‪−1.79 M‬ AUD, and current EBITDA margin is −17.09%. See more stats in ANAGENICS LIMITED financial statements.